Jonathan Yingling
Hoofd Techniek/Wetenschap/O&O bij ARCUS BIOSCIENCES, INC.
Actieve functies van Jonathan Yingling
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 | - |
Loopbaan van Jonathan Yingling
Eerdere bekende functies van Jonathan Yingling
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2018 | 31-01-2020 |
| Corporate Officer/Principal | 06-02-2017 | 01-01-2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-06-2013 | 01-10-2015 |
| DNIB UNWIND INC | Hoofd Techniek/Wetenschap/O&O | 16-12-2015 | - |
Opleiding van Jonathan Yingling
| Duke University School of Medicine | Doctorate Degree |
| The College of William & Mary | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Beurs
- Insiders
- Jonathan Yingling
- Ervaring
